Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M--Revenue $M--Net Margin (%)--Altman Z-Score
Enterprise Value $M--EPS $--Operating Margin %--Piotroski F-Score--
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M--ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with XLV

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
XLVKen Fisher 2015-12-31 Add$66.86 - $72.99
($70.76)
$ 64.40-9%Add 2.64%293,541
XLVKen Fisher 2015-09-30 Add$64.29 - $77.22
($73.06)
$ 64.40-12%Add 5.33%285,985
XLVLeon Cooperman 2015-06-30 Sold Out -0.42%$71.46 - $76.45
($73.85)
$ 64.40-13%Sold Out0
XLVKen Fisher 2015-06-30 Add$71.71 - $76.45
($74.07)
$ 64.40-13%Add 5.40%271,515
XLVLeon Cooperman 2015-03-31 Buy 0.42%$67.86 - $74.9
($71.15)
$ 64.40-9%New holding366,000
XLVKen Fisher 2015-03-31 Add$68.05 - $74.9
($71.32)
$ 64.40-10%Add 4.15%257,614
XLVKen Fisher 2014-06-30 Add0.01%$55.71 - $61.23
($58.7)
$ 64.4010%Add 34.36%226,412
XLVGeorge Soros 2012-09-30 Sold Out -0.03%$37.27 - $40.3
($38.73)
$ 64.4066%Sold Out0
XLVGeorge Soros 2012-06-30 Buy 0.03%$35.52 - $37.87
($36.91)
$ 64.4074%New holding50,000
XLVKen Fisher 2012-06-30 Add$35.52 - $37.87
($36.91)
$ 64.4074%Add 53.52%119,754
XLVKen Fisher 2011-06-30 Buy 0.01%$33.28 - $36.42
($34.99)
$ 64.4084%New holding86,997
XLVGeorge Soros 2011-03-31 Sold Out $31.5 - $33.18
($32.33)
$ 64.4099%Sold Out0
XLVGeorge Soros 2010-12-31 Reduce-0.15%$30.19 - $31.78
($31.13)
$ 64.40107%Reduce -93.88%34,153
XLVGeorge Soros 2010-09-30 Buy 0.25%$28.03 - $30.68
($29.2)
$ 64.40121%New holding558,053
XLVGeorge Soros 2010-06-30 Sold Out $28.38 - $32.31
($30.13)
$ 64.40114%Sold Out0
XLVGeorge Soros 2010-03-31 Reduce$30.68 - $33
($31.72)
$ 64.40103%Reduce -43.59%6,600
XLVGeorge Soros 2009-12-31 Buy 0.01%$28.07 - $31.62
($30.04)
$ 64.40114%New holding11,700
XLVBill Gates 2009-06-30 Sold Out -4.19%$23.76 - $26.53
($25.04)
$ 64.40157%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

XLV is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


XLV: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Vanzeyst, Albert Wilhelmus10% Security Holder 2016-02-04Sell135,000$0.867388.37view
Anwyll, Edward William DrewSenior Officer 2016-02-04Sell4,000$18.75243.47view
Galloway, JulieSenior Officer 2016-02-04Sell16,600$18.5248.11view
Higgs, Darcy Alan10% Security Holder 2016-02-04Sell18,025$0.416000view
Higgs, DennisDirector 2016-02-04Sell18,025$0.416000view
Taylor, Larry DouglasDirector 2016-02-04Buy36,000$0.164300view
Paquette, Raymon Lucien10% Security Holder, Director, Senior Officer 2016-02-04Buy5,000$0.1158445.45view
Hinchcliffe, Robert10% Security Holder, Director, Senior Officer 2016-02-04Buy30,000$0.164300view
Schellenberg, Gary David AlberDirector, Senior Officer 2016-02-04Buy20,000$0.06107233.33view
Schellenberg, Gary David AlberDirector, Senior Officer 2016-02-04Buy13,000$0.06107233.33view

Quarterly/Annual Reports about XLV:

    News about XLV:

    Articles On GuruFocus.com
    Yacktman Fund Comments on Staples Feb 05 2016 
    Yacktman Fund Comments on Apollo Feb 05 2016 
    Yacktman Fund Comments on C.H. Robinson Feb 05 2016 
    Yacktman Fund Comments on PepsiCo Feb 05 2016 
    Yacktman Fund Comments on P&G Feb 05 2016 
    Yacktman Fund Comments on Microsoft Feb 05 2016 
    Auxier Asset Management Year-End 2015 Market Commentary Feb 05 2016 
    On Running a Concentrated Portfolio Feb 05 2016 
    Mario Gabelli Comments on Rolls-Royce Holding plc Feb 05 2016 
    Mario Gabelli Comments on Legg Mason Inc. Feb 05 2016 

    More From Other Websites
    Job growth slows, unemployment falls; oil tax; health insurance alliance Feb 05 2016
    Aetna Posted Higher-than-Expected Earnings per Share in 4Q15 Feb 04 2016
    Rationale for the Alere–Abbott Laboratories Merger Feb 04 2016
    Abbott Labs Beefs Up Its Diagnostics Portfolio with Alere Feb 04 2016
    Parsing the Baxalta–Shire Material Adverse Effect Clause, Part 2 Feb 01 2016
    Analysts Expect MDT’s Fiscal 3Q16 Revenues to be $6.9 Million Feb 01 2016
    Strong Revenue for Abbott Point of Care Diagnostics Division Feb 01 2016
    Can Boston Scientific Maintain Its Growth Momentum? Feb 01 2016
    Parsing the Baxalta–Shire Material Adverse Effect Clause, Part 1 Jan 31 2016
    Becton, Dickinson and Company’s 1Q16 Earnings Estimates Jan 30 2016
    Vertex Will Focus on Cystic Fibrosis Market in 2016 Jan 30 2016
    How Much Is Teva Spending on Research and Development? Jan 29 2016
    Anthem’s Commercial and Specialty Enrollments Rose by 0.31 Million in 2015 Jan 29 2016
    Health care fundamentals still very strong: Manley Jan 29 2016
    If history rhymes this indicator suggests stocks still have a long way to fall Jan 29 2016
    Is this a sucker's bottom? Jan 29 2016
    Top trades for the 2nd half: Earnings ahead Jan 29 2016
    Analysts Expect Mylan’s Growth to Be at 29.7% for 4Q15 Jan 28 2016
    Vertex’s Cystic Fibrosis Drugs and Their Controversial Prices Jan 28 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    Purcelm2
    ReplyPurcelm2 - 1 year ago
    1
    Gurufocus
    ReplyGurufocus - 2 years ago
    test
    Don Li
    ReplyDon Li - 2 years ago
    test 38
    Gurufocus
    ReplyGurufocus - 2 years ago
    test37
    Gurufocus
    ReplyGurufocus - 2 years ago
    test 36
    Don Li
    ReplyDon Li - 2 years ago
    test 24
    Don Li
    ReplyDon Li - 2 years ago
    test 23
    Rommy
    ReplyRommy - 2 years ago
    How do I create portfolio using GureFocus?
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK